Westwood Holdings Group Inc. Has $15.24 Million Stock Holdings in Teleflex Incorporated (NYSE:TFX)

Westwood Holdings Group Inc. decreased its stake in Teleflex Incorporated (NYSE:TFX - Free Report) by 9.9% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 110,273 shares of the medical technology company's stock after selling 12,078 shares during the period. Westwood Holdings Group Inc. owned 0.24% of Teleflex worth $15,239,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in TFX. Invesco Ltd. boosted its stake in Teleflex by 48.1% during the 4th quarter. Invesco Ltd. now owns 1,068,593 shares of the medical technology company's stock valued at $190,188,000 after purchasing an additional 347,003 shares during the period. Diamond Hill Capital Management Inc. increased its stake in shares of Teleflex by 122.8% in the first quarter. Diamond Hill Capital Management Inc. now owns 584,586 shares of the medical technology company's stock valued at $80,784,000 after purchasing an additional 322,222 shares during the period. T. Rowe Price Investment Management Inc. raised its holdings in shares of Teleflex by 4.4% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 6,173,121 shares of the medical technology company's stock valued at $1,098,693,000 after buying an additional 261,279 shares during the last quarter. Principal Financial Group Inc. boosted its position in shares of Teleflex by 229.9% during the first quarter. Principal Financial Group Inc. now owns 230,522 shares of the medical technology company's stock worth $31,856,000 after buying an additional 160,646 shares during the period. Finally, Deutsche Bank AG increased its position in Teleflex by 62.5% in the 4th quarter. Deutsche Bank AG now owns 407,129 shares of the medical technology company's stock valued at $72,461,000 after acquiring an additional 156,524 shares during the period. Institutional investors and hedge funds own 95.62% of the company's stock.

Analyst Ratings Changes

Several analysts have weighed in on TFX shares. Mizuho lifted their target price on Teleflex from $130.00 to $135.00 and gave the company a "neutral" rating in a research note on Friday, August 1st. Truist Financial lowered their price target on Teleflex from $140.00 to $137.00 and set a "hold" rating on the stock in a report on Monday, May 5th. Wells Fargo & Company reduced their price objective on shares of Teleflex from $137.00 to $131.00 and set an "equal weight" rating for the company in a report on Friday, August 1st. Wall Street Zen raised shares of Teleflex from a "hold" rating to a "strong-buy" rating in a research note on Saturday, August 2nd. Finally, Morgan Stanley dropped their price target on shares of Teleflex from $191.00 to $173.00 and set an "overweight" rating on the stock in a research report on Monday, May 5th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating, one has given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $141.57.

Insider Activity

In related news, CEO Liam Kelly purchased 1,500 shares of Teleflex stock in a transaction on Tuesday, August 5th. The stock was bought at an average price of $115.07 per share, with a total value of $172,605.00. Following the completion of the transaction, the chief executive officer directly owned 45,267 shares of the company's stock, valued at approximately $5,208,873.69. This represents a 3.43% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Andrew A. Krakauer acquired 1,000 shares of the stock in a transaction dated Tuesday, August 5th. The shares were bought at an average cost of $115.25 per share, for a total transaction of $115,250.00. Following the acquisition, the director owned 7,192 shares in the company, valued at $828,878. The trade was a 16.15% increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders have purchased 5,500 shares of company stock valued at $633,590. 1.40% of the stock is currently owned by company insiders.

Teleflex Price Performance

NYSE TFX traded up $3.08 on Friday, reaching $118.57. The company's stock had a trading volume of 701,177 shares, compared to its average volume of 582,619. Teleflex Incorporated has a twelve month low of $108.90 and a twelve month high of $249.90. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.44 and a current ratio of 2.41. The firm's 50 day moving average is $118.09 and its two-hundred day moving average is $134.92. The stock has a market cap of $5.24 billion, a PE ratio of 27.90, a PEG ratio of 1.61 and a beta of 1.08.

Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The medical technology company reported $3.73 earnings per share for the quarter, topping the consensus estimate of $3.36 by $0.37. The firm had revenue of $780.90 million for the quarter, compared to analysts' expectations of $771.53 million. Teleflex had a net margin of 6.31% and a return on equity of 15.08%. The company's quarterly revenue was up 4.2% compared to the same quarter last year. During the same period in the previous year, the company posted $3.42 EPS. As a group, sell-side analysts predict that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, September 15th. Investors of record on Friday, August 15th will be given a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend is Friday, August 15th. Teleflex's dividend payout ratio (DPR) is presently 32.00%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.